Spirovant Sciences has a total of 37 patents globally, out of which no patents have been granted. Of these 37 patents, more than 89% patents are active. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Spirovant Sciences.
Spirovant Sciences was founded in the year 2016. The Company is developing novel gene therapies for cystic fibrosis and other pulmonary diseases.
Do read about some of the most popular patents of Spirovant Sciences which have been covered by us in this article and also you can find Spirovant Sciences patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Spirovant Sciences patent portfolio.
How many patents does Spirovant Sciences have?
Spirovant Sciences has a total of 37 patents globally. These patents belong to 8 unique patent families. Out of 37 patents, 33 patents are active.
How Many Patents did Spirovant Sciences File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Spirovant Sciences Applications Filed | Spirovant Sciences Patents Granted |
| 2023 | 2 | – |
| 2022 | 6 | – |
| 2021 | 5 | – |
| 2020 | 22 | – |
How many Spirovant Sciences patents are Alive/Dead?
How Many Patents did Spirovant Sciences File in Different Countries?
Countries in which Spirovant Sciences Filed Patents
| Country | Patents |
| Israel | 3 |
| United States Of America | 3 |
| Australia | 3 |
| Brazil | 3 |
| Canada | 3 |
| Japan | 3 |
| Europe | 2 |
| Indonesia | 2 |
| Singapore | 2 |
| Mexico | 2 |
| Viet Nam | 2 |
| New Zealand | 2 |
| Hong Kong (S.A.R.) | 2 |
| Philippines | 2 |
Where are Research Centres of Spirovant Sciences Patents Located?
What Percentage of Spirovant Sciences US Patent Applications were Granted?
Spirovant Sciences (Excluding its subsidiaries) has filed 1 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 0 have been granted leading to a grant rate of 0.0%.
Below are the key stats of Spirovant Sciences patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Spirovant Sciences?
| Law Firm | Total Applications | Success Rate |
| Schwegman Lundberg & Woessner | 1 | 0% |
List of Spirovant Sciences Patents
| Spirovant Sciences Patents | Title |
| US20230242941A1 | Methods And Compositions For Administering Recombinant Viral Vectors |
| US20220241436A1 | Compositions And Methods For Treatment Of Cystic Fibrosis |
| US20220195461A1 | Methods And Compositions For Transgene Expression |
| EP3955971A1 | Compositions And Methods For Treatment Of Cystic Fibrosis |
| EP3955970A1 | Methods And Compositions For Transgene Expression |
| BR112023021377A2 | Methods And Compositions For Treatment Of Cystic Fibrosis |
| AU2022256510A9 | Methods And Compositions For Treatment Of Cystic Fibrosis |
| IL307709A | Methods And Compositions For Treatment Of Cystic Fibrosis |
| JP2023126658A5 | Methods And Compositions For Transgene Expression |
| JP2022529457A5 | Compositions And Methods For The Treatment Of Cystic Fibrosis |
| CA3216495A1 | Methods And Compositions For Treatment Of Cystic Fibrosis |
| BR112021020706A2 | Methods And Compositions For Transgene Expression |
| BR112021020708A2 | Compositions And Methods For Treatment Of Cystic Fibrosis |
| AU2020260076A1 | Compositions And Methods For Treatment Of Cystic Fibrosis |
| AU2020257182A1 | Methods And Compositions For Transgene Expression |
| IL287260A | Compositions And Methods For Treatment Of Cystic Fibrosis |
| IL287262A | Methods And Compositions For Transgene Expression |
| CA3137078A1 | Methods And Compositions For Transgene Expression |
| CA3137015A1 | Compositions And Methods For Treatment Of Cystic Fibrosis |
| VN92403A | Methods And Products For Transfer Genes Expression |
| VN92404A | Products And Treatment Methods Of Cystic Fibrosis |
| HK40068813A | Compositions And Methods For Treatment Of Cystic Fibrosis |
| HK40068814A | Methods And Compositions For Transgene Expression |
| PH12021552610A1 | Compositions And Methods For Treatment Of Cystic Fibrosis |
| PH12021552609A1 | Methods And Compositions For Transgene Expression |
| MX2021012681A | Compositions And Methods For Treatment Of Cystic Fibrosis. |
| MX2021012682A | Methods And Compositions For Transgene Expression. |
| ID202201557A | Composition And Methods For The Treatment Of Systic Fibrosis |
| ID202201556A | Method And Composition For Transgen Expression |
| SG11202111334SA | Compositions And Methods For Treatment Of Cystic Fibrosis |
| SG11202111353QA | Methods And Compositions For Transgene Expression |
| NZ782151A | Methods And Compositions For Transgene Expression |
| NZ782149A | Compositions And Methods For Treatment Of Cystic Fibrosis |
| WO2022221684A1 | Methods And Compositions For Treatment Of Cystic Fibrosis |
| JP2022529470A | Methods And Compositions For Transgene Expression |
| WO2020214668A1 | Compositions And Methods For Treatment Of Cystic Fibrosis |
| WO2020214672A1 | Methods And Compositions For Transgene Expression |
What are Spirovant Sciences key innovation segments?
What Technologies are Covered by Spirovant Sciences?
The chart below distributes patents filed by Spirovant Sciences